Amid a barrage of research on finding treatment for new coronavirus, Australian scientists have found that a common anti-parasitic drug killed SARS-CoV-2 virus, growing in cell culture, within 48 hours in lab settings.
Ivermectin is an FDA-approved anti-parasitic drug that has also been shown to be effective in vitro against a broad range of viruses including HIV, dengue, influenza and zika virus.
Published in the journal Antiviral Research, the study from Monash University showed that a single dose of Ivermectin could stop the coronavirus growing in cell culture -- effectively eradicating all genetic material of the virus within two days.
"We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it," said study lead author Dr Kylie Wagstaff.
Dr Wagstaff, however, cautioned that the tests conducted in the study were in vitro and that trials needed to be carried out in people.
"Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it at in humans will be effective - that's the next step," Wagstaff informed.
In times when we're having a global pandemic and there isn't an approved treatment, "if we had a compound that was already available around the world then that might help people sooner".
"Realistically it's going to be a while before a vaccine is broadly available," she said.
Although the mechanism by which Ivermectin works on the virus is not known, it is likely, based on its action in other viruses, that it works to stop the virus 'dampening down' the host cells' ability to clear it.
Dr Wagstaff made a previous breakthrough finding on Ivermectin in 2012 when she identified the drug and its antiviral activity with Monash Biomedicine Discovery Institute's Professor David Jans, also an author on this paper.
Professor Jans and his team have been researching Ivermectin for more than 10 years with different viruses.
Dr Wagstaff and Professor Jans started investigating whether it worked on the SARS-CoV-2 virus as soon as the pandemic was known to have started.
The use of Ivermectin to combat COVID-19 depends on pre-clinical testing and clinical trials, with funding urgently required to progress the work, the researchers noted.
Tripura closes all schools for 4 days due to heat wave conditions
With the state buffeted by a heat wave, the Tripura government on Wednesday declared a holiday in all schools for four days from Wednesday to provide respite to children.
All three units of EVMs have their own microcontroller, ECI tells SC
The Election Commission of India (ECI) on Wednesday apprised the Supreme Court that all three units (i.e. ballot unit, control unit and VVPAT) of the Electronic Voting Machines (EVMs) have their own microcontroller.
Congress ready to set 'dangerous precedent' by implementing Inheritance Tax: PM Modi
Prime Minister Narendra Modi on Wednesday slammed the Congress, saying that the party seeks to destroy the ordinary people of India economically and is about to set a "dangerous precedent" by implementing an 'Inheritance Tax' if voted to power.
PM Modi has lifted 400 million people out of poverty: JP Morgan CEO
Prime Minister Narendra Modi has taken 400 million (40 crore) people out of poverty and is doing an “unbelievable job” in India, Global banking giant JP Morgan Chase chief executive officer (CEO) Jamie Dimon has said.
India to become one of biggest chip hubs in next 5 years: Ashwini Vaishnaw
India has commissioned four semiconductor manufacturing units and in the next five years, the country will become one of the biggest semiconductor hubs in the world, Union Railways and IT Minister Ashwini Vaishnaw has said.
PM Modi highlights need for resilient infrastructure at 39-nation meet on natural disasters
Prime Minister Narendra Modi on Wednesday emphasised the need to invest in resilient infrastructure as part of the strategy to minimise the damage from natural disasters that are on the rise across the world.
India calls for ‘gender-responsive arms control’ to prevent sexual violence in conflicts
To combat sexual violence in conflict situations, India has advocated a multifaceted approach which includes “gender-responsive arms control” that prevents the proliferation of weapons.
Pressing UNSC reforms, India highlights consensus in G20 with broader membership
Pressing the case for Security Council reforms, India has highlighted the consensus arrived at the more representative G20 Summit on issues that could not make it through the UN's highest decision-making body stuck in a "cold war" mode.